Data on the Adoption of Decentralized Methods in Cancer Trials During the Pandemic
2024-06-11 Hosts Craig Lipset, Dr. Amir Kalali, and Jane Myles were joined by Dr. Timil Patel, a Medical Oncologist with the FDA for a discussion around the recently released ASCO abstract around adoption of decentralized trial elements in cancer clinical trials during the pandemic.
Clinical Trials Transformation Initiative (CTTI) and FDA (with support from Decentralized Trials & Research Alliance (DTRA) collected data from research sponsors to understand the methods that were adopted, the associated challenges to address, and the direction ahead.
Read the ASCO abstract here –> https://meetings.asco.org/abstracts-presentations/237149
You can join TGIF-DTRA Sessions live on LinkedIn Live Audio on Friday’s at 12:00 PM ET by checking out our LinkedIn. Follow the Decentralized Trials & Research Alliance (DTRA) on LinkedIn and X. Learn more about Membership options and our work at www.dtra.org.
